Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis
Dmitry Victorovich Garbuzenko
World Journal of Clinical Cases (2022) Vol. 10, Iss. 12, pp. 3662-3676
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
Qiying Pei, Qian Yi, Liling Tang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9671-9671
Open Access | Times Cited: 50
Ferroptosis in organ fibrosis: From mechanisms to therapeutic medicines
Weijing Lai, Bo Wang, Rongshuang Huang, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 22-34
Open Access | Times Cited: 6
Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
Janitha M. Unagolla, Subarna Das, Riley Flanagan, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124381-124381
Closed Access | Times Cited: 6
DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling
Qingqing Liu, Jing Chen, Tao Ma, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis
Mengqin Yuan, Lichao Yao, Ping Chen, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111134-111134
Open Access | Times Cited: 12
The role of lncRNA-mediated ceRNA regulatory networks in liver fibrosis
Jianhao Jiang, Ilgiz Gareev, Tatiana Ilyasova, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 463-470
Open Access | Times Cited: 4
Advances in precision gene editing for liver fibrosis: From technology to therapeutic applications
Peng Ji, Yan Li, Zihan Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117003-117003
Open Access | Times Cited: 4
Nanoparticle: Pathogenesis, Innovative Diagnosis, and Therapy of Liver Fibrosis
Wen Lin, X Liu, Dejun Yang, et al.
ChemistrySelect (2025) Vol. 10, Iss. 7
Closed Access
The Covert Side of Ascites in Cirrhosis: Cellular and Molecular Aspects
Carlo Airola, Simone Varca, Angelo Del Gaudio, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 680-680
Open Access
Combined quercetin with phosphodiesterase inhibitors; sildenafil and pentoxifylline alleviated CCl4-induced chronic hepatic fibrosis: Role of redox-sensitive pathways
Gehad Nasr, Doaa Mohamed Elroby Ali, Michael Atef Fawzy, et al.
Food and Chemical Toxicology (2025), pp. 115442-115442
Closed Access
The role of hepatic sinusoidal microenvironment in NASH: pathogenesis, animal models, and therapeutic prospects
Wanying Tan, Jiong Deng, Lingjun Qi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Mechanisms of Epigenetic Regulation in the Fibrogenic Activation of Hepatic Stellate Cells in Non-alcoholic Fatty Liver Disease
Dmitry Victorovich Garbuzenko
Gene Expression (2024) Vol. 23, Iss. 1, pp. 31-43
Open Access | Times Cited: 3
BRD4: an effective target for organ fibrosis
Qun Wei, Cailing Gan, Meng Sun, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Serum α-SMA is a potential noninvasive biomarker of liver fibrosis
Irina Cardoso-Lezama, Erika Ramos‐Tovar, Jaime Arellanes‐Robledo, et al.
Toxicology Mechanisms and Methods (2023) Vol. 34, Iss. 1, pp. 13-19
Closed Access | Times Cited: 8
Melatonin ameliorates hepatic fibrosis via the melatonin receptor 2-mediated upregulation of BMAL1 and anti-oxidative enzymes
Jea Il Kim, Hyae Gyeong Cheon
European Journal of Pharmacology (2024) Vol. 966, pp. 176337-176337
Closed Access | Times Cited: 2
A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis
Osama A. Mohammed, Mahmoud E. Youssef, Ahmed S. Doghish, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 198, pp. 106792-106792
Open Access | Times Cited: 2
Jiawei Taohe Chengqi Decoction attenuates CCl4 induced hepatic fibrosis by inhibiting HSCs activation via TGF-β1/CUGBP1 and IFN-γ/Smad7 pathway
Linmao Ye, Jiaxin Huang, Xiaofan Liang, et al.
Phytomedicine (2024) Vol. 133, pp. 155916-155916
Closed Access | Times Cited: 2
Cryptotanshinone induces apoptosis of activated hepatic stellate cells via modulating endoplasmic reticulum stress
Xiao-Xue Hou, Yuwen Li, Jiali Song, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 17, pp. 2616-2627
Open Access | Times Cited: 6
Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis
Rui Tang, Jing Luo, Xiaoxia Zhu, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6
METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2–dependent mechanism
Xiaoxue Hou, Yuwen Li, Jiali Song, et al.
Hepatology Communications (2023) Vol. 7, Iss. 8
Open Access | Times Cited: 5
The mechanical mechanism of angiotensin II induced activation of hepatic stellate cells promoting portal hypertension
Yiheng Zhang, Mulan Xing, Fansheng Meng, et al.
European Journal of Cell Biology (2024) Vol. 103, Iss. 2, pp. 151427-151427
Open Access | Times Cited: 1
A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1–JNK pathway‐dependent chemokines
Keiya Watakabe, Masato Miyoshi, Sei Kakinuma, et al.
The FASEB Journal (2024) Vol. 38, Iss. 13
Closed Access | Times Cited: 1
Schistosoma antigens: A future clinical magic bullet for autoimmune diseases?
Mphatso Chaponda, Ho Yin Pekkle Lam
Parasite (2024) Vol. 31, pp. 68-68
Open Access | Times Cited: 1
An overview of pathogenesis of metabolic dysfunction-associated steatotic liver disease
Shahid Habib, Andrew Johnson
(2024), pp. 459-473
Open Access | Times Cited: 1
miR-541 is associated with the prognosis of liver cirrhosis and directly targets JAG2 to inhibit the activation of hepatic stellate cells
Jinpei Liu, Shaohua Song, Pei‐Mei Shi, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top